BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gao CC, Ding FF, Jiang X. RRM2 attenuates the renal tubular ferroptosis in diabetic kidney disease through PI3K/Akt/Nrf2 pathway. World J Diabetes 2025; 16(11): 111223 [PMID: 41278435 DOI: 10.4239/wjd.v16.i11.111223]
URL: https://www.wjgnet.com/1948-9358/full/v16/i11/111223.htm
Number Citing Articles
1
Ying-Chun Liu, Jing Xiao, Lin Chen. RRM2 attenuates renal tubular ferroptosis in diabetic kidney disease <i>vi</i>a the PI3K/Akt/Nrf2 pathway: Strengths, limitations, and future research directions. World Journal of Diabetes 2026; 17(2): 115021 doi: 10.4239/wjd.v17.i2.115021
2
Min Huang, Bo Xu, Hang Qi, Hongzhou Xu, Liang Cai. Ligustilide alleviates sepsis-associated acute kidney injury by activating Nrf2/HO-1 and PI3K/Akt signaling pathways. The International Journal of Biochemistry & Cell Biology 2026;  doi: 10.1016/j.biocel.2026.106945
3
Tong-Jian Zhao, Nian-Zhe Sun. <i>RRM2</i> and the ferroptosis-oxidative stress axis in diabetic kidney disease: Emerging insights from recent evidence. World Journal of Diabetes 2026; 17(8): 115342 doi: 10.4239/wjd.115342
4
Jianzong Xuan, Renhua Ding, Haiyin Zhang, Yiyuan Wang, Liangliang Wu, Yuan Liu, Jianrui Dong, Ran Hu. Cell-state- and compartment-dependent PI3K/Akt redox signaling in chronic kidney disease: mechanisms and translational implications. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1951798